Could CT screening for lung cancer ever be cost effective in the United Kingdom?

Cost Effectiveness and Resource Allocation

Volumn 6, Issue , 2008, Pages

  Whynes, David K ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL PARAMETERS; ARTICLE; CANCER DIAGNOSIS; CANCER MODEL; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; GOVERNMENT REGULATION; HEALTH CARE COST; HIGH RISK POPULATION; LUNG CANCER; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MEDICAL AUDIT; QUALITY ADJUSTED LIFE YEAR; RISK ASSESSMENT; UNITED KINGDOM;

EID: 42249108699     PISSN: None     EISSN: 14787547     Source Type: Journal    
DOI: 10.1186/1478-7547-6-5     Document Type: Article

References (73)

1. Ellis JRC Gleeson FV Lung cancer screening British Journal of Radiology 2001, 74:478-485. 11459725
2. Xu DM Gietema H de Koning H Vernhout R Nackaerts K Prokop M Weenink C Lammers J-W Groen H Oudkerk M van Klaverend R Nodule management protocol of the NELSON randomised lung cancer screening trial Lung Cancer 2006, 54:177-184. 10.1016/j.lungcan.2006.08.006 16989922
3. Infante M Lutman FR Cavuto S Brambilla G Chiesa G Passera E Angeli E Chiarenza M Aranzulla G Cariboni C Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial Lung Cancer 2007. doi:10.1016/j.lungcan.2007.1008.1040 17936405
4. Jett JR Midthun DE Screening for lung cancer: Current status and future directions Chest 2004, 125:158-162. 10.1378/chest.125.5_suppl.158S
5. Hunink MGM Gazelle GS CT screening: A trade-off of risks, benefits, and costs Journal of Clinical Investigation 2003, 111:1612-1619. 156117 12782661
6. Gleeson FV Is screening for lung cancer using low dose spiral CT scanning worthwhile? Thorax 2006, 61:5-7. 10.1136/thx.2005.042325 16396951
7. Reich JM Assessing the efficacy of lung cancer screening Radiology 2006, 238:398-401. 10.1148/radiol.2382050668 16436807
8. Midthun DE Swensen SJ Jett JR Lung cancer screening results: Easily misunderstood Mayo Clinic Proceedings 2007, 82:14-15. 17285781
9. McMahon PM Christiani DC Computed tomography screening for lung cancer British Medical Journal 2007, 334:271. 1796677 17289689 10.1136/ bmj.39090.662963.80
10. Black WC Baron JA CT screening for lung cancer: Spiraling Into confusion? Journal of the American Medical Association 2007, 297:995-996. 10.1001/jama.297.9.995 17341714
11. Black C Bagust A Boland A Walker S McLeod C De Verteuil R Ayres J Bain L Thomas S Godden D Waugh N The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews Health Technology Assessment 2006, 10:.
12. Okamoto N Cost-effectiveness of lung cancer screening in Japan Cancer 2000, 89:2489-2493. 10.1002/1097-0142(20001201)89:11+ <2489::AID-CNCR29>3.0.CO;2-E 11147633
13. Chirikos TN Hazelton T Tockman M Clark R Screening for lung cancer with CT: A preliminary cost-effectiveness analysis Chest 2002, 121:1507-1514. 10.1378/chest.121.5.1507 12006436
14. Mahadevia PJ Fleisher LA Frick KD Eng J Goodman SN Powe NR Lung cancer screening with helical computed tomography in older adult smokers: A decision and cost-effectiveness analysis Journal of the American Medical Association 2003, 289:313-322. 10.1001/jama.289.3.313 12525232
15. Marshall D Simpson KN Earle CC Chu C-W Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort Lung Cancer 2001, 32:227-236. 10.1016/S0169-5002(00)00239-7 11390004
16. Marshall D Simpson KN Earle CC Chu C-W Economic decision analysis model of screening for lung cancer European Journal of Cancer 2001, 37:1759-1767. 10.1016/S0959-8049(01)00205-2 11549429
17. Wisnivesky JP Mushlin AI Sicherman N Henschke C The cost-effectiveness of low-dose CT screening for lung cancer: Preliminary results of baseline screening Chest 2003, 124:614-621. 10.1378/chest.124.2.614 12907551
18. Manser R Dalton A Carter R Byrnes G Elwood M Campbell DA Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting Lung Cancer 2005, 48:171-185. 10.1016/j.lungcan.2004.11.001 15829317
19. National Institute for Health and Clinical Excellence Social value judgements: Principles for the development of NICE guidance London: NIHCE 2005
20. Goeree R Burke N O'Reilly D Manca A Blackhouse G Tarride J-E Transferability of economic evaluations: Approaches and factors to consider when using results from one geographic area for another Current Medical Research and Opinion 2007, 23(4):671-682. 10.1185/ 030079906X167327 17407623
21. Whynes DK Cost-effectiveness of faecal occult blood screening for colorectal cancer: Results of the Nottingham trial Critical Reviews in Oncology/Hematology 1999, 32:155-165. 10.1016/S1040-8428(99)00021-9 10612015
22. National Institute for Clinical Excellence Clinical Guideline 24: Lung cancer: The diagnosis and treatment of lung cancer London: NICE 2005
23. National Institute for Clinical Excellence Clinical Guideline 24: National cost-impact report to accompany 'Lung cancer: The diagnosis and treatment of lung cancer' London: NICE 2005
24. Comptroller and Auditor General The performance of the NHS cervical screening programme in England, HC 678 1997/98 London: National Audit Office 1998
25. Laroche C Fairbairn I Moss H Pepke-Zaba J Sharples L Flower C Coulden R Role of computed tomographic scanning of the thorax prior to bronchoscopy in the investigation of suspected lung cancer Thorax 2000, 55:359-363. 10.1136/thorax.55.5.359 10770815
26. Wolstenholme JL Whynes DK The hospital costs of treating lung cancer in the United Kingdom British Journal of Cancer 1999, 80:215-218. 10.1038/ sj.bjc.6690341 10389998
27. Oliver E Killen J Kiebert G Hutton J Hall R Higgins B Bourke S Paschen B Treatment pathways, resource use and costs in the management of small cell lung cancer Thorax 2001, 56:785-790. 10.1136/thorax.56.10.785 11562518
28. Allgar VL Neal RD Delays in the diagnosis of six cancers: Analysis of data from the National Survey of NHS Patients: Cancer British Journal of Cancer 2005, 92:1959-1970. 10.1038/sj.bjc.6602587 15870714
29. The Information Centre for Health and Social Care National lung cancer audit: Key findings about the quality of care for people with lung cancer in England incorporating headline and completeness data from Wales Leeds: Information Centre 2006
30. Guest JF Ruiz FJ Greener MJ Trotman IF Palliative care treatment patterns and associated costs of healthcare resource use for specific advanced cancer patients in the UK European Journal of Cancer Care 2006, 15:65-73. 10.1111/j.1365-2354.2005.00623.x 16441679
31. Black WC Computed tomography screening for lung cancer Cancer 2007, 110:2370-2384. 10.1002/cncr.23059 17941031
32. Swensen SJ Jett JR Hartman TE Midthun DE Mandrekar SJ Hillman SL Sykes A-M Aughenbaugh GL Bungum AO Allen KL CT screening for lung cancer: five-year prospective experience Radiology 2005, 235:259-265. 10.1148/ radiol.2351041662 15695622
33. Bepler G Carney DG Djulbegovic B Clark RA Tockman M A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest Cancer Control 2003, 10:306-314. 12915809
34. Diederich S Thomas M Semik M Lenzen H Roos N Weber A Heindel W Wormanns D Screening for early lung cancer with low-dose spiral computed tomography: Results of annual follow-up examinations in asymptomatic smokers European Radiology 2004, 14:691-702. 10.1007/s00330-003-2200-5 14727146
35. MacRedmond R Logan PM Lee M Kenny D Foley C Costello RW Screening for lung cancer using low dose CT scanning Thorax 2004, 59:237-241. 10.1136/ thx.2003.008821 14985561
36. Pastorino U Bellomi M Landoni C De Fiori E Arnaldi P Picchio M Pelosi G Boyle P Fazio F Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results Lancet 2003, 362:593-597. 10.1016/S0140-6736(03)14188-8 12944057
37. Government Actuary's Department London: GAD 2007 http://www.gad.gov.uk/ Demography_Data/Life_Tables/methodology.asp
38. Government Actuary's Department London: GAD 2007
39. National Collaborating Centre for Acute Care The diagnosis and treatment of lung cancer: Methods, evidence, guidance London: NCCAC 2005
40. Office of National Statistics London: ONS 2007
41. Fry WA Phillips JL Menck HR Ten-year survey of lung cancer treatment and survival in hospitals in the United States Cancer 1999, 86:1867-1876. 10.1002/(SICI)1097-0142(19991101)86:9<1867::AID-CNCR31>3.0.CO;2-9 10547562
42. International Early Lung Cancer Action Program Investigators Survival of patients with stage 1 lung cancer detected on CT screening New England Journal of Medicine 2006, 355:1763-1771. 10.1056/NEJMoa060476 17065637
43. Sone S Nakayama T Honda T Tsushima K Li F Haniuda M Takahashi Y Suzuki T Yamanda T Kondo R Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography Lung Cancer 2007, 58:329-341. 10.1016/ j.lungcan.2007.06.022 17675180
44. van Klaveren RJ Habbema JDF Pedersen JH de Koning HJ Oudkerkz M Hoogsteden HC Lung cancer screening by low-dose spiral computed tomography European Respiratory Journal 2001, 18:857-866. 10.1183/ 09031936.01.00076701 11757637
45. Henschke CI Yankelevitz DF Kostis WJ CT screening for lung cancer Seminars in Ultrasound, CT, and MRI 2003, 24(1):23-32. 10.1016/ S0887-2171(03)90022-9 12708641
46. National Institute for Clinical Excellence Guide to the methods of technology appraisal, N0515 London: NICE 2004
47. Sugimura H Yang P Long-term survivorship in lung cancer: A review Chest 2006, 129:1088-1097. 10.1378/chest.129.4.1088 16608961
48. Trippoli S Vaiani M Lucioni C Messori A Quality of Life Study Group of the Master 2 Project in Pharmacoeconomics Quality of life and utility in patients with non-small cell lung cancer Pharmacoeconomics 2001, 19:855-863. 10.2165/00019053-200119080-00007 11596837
49. Ko CY Maggard M Livingston EH Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: A nationwide, population-based assessment Journal of Surgical Research 2003, 114:1-5. 10.1016/S0022-4804(03)00167-7 13678691
50. van den Hout WB Kramer GWPM Noordijk EM Leer J-WH Cost-utility analysis of short-versus long-course palliative radiotherapy in patients with non-small-cell lung cancer Journal of the National Cancer Institute 2006, 98:1786-1794. 17179480
51. Yang P Allen MS Aubry MC Wampfler JA Marks RS Edell ES Thibodeau S Adjei AA Jett J Deschamps C Clinical features of 5,628 primary lung cancer patients: Experience at Mayo Clinic from 1997 to 2003 Chest 2005, 128:452-462. 10.1378/chest.128.1.452 16002972
52. Whynes DK Frew EJ Edwards R Atkin WS Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom International Journal of Technology Assessment in Health Care 2003, 19:384-395. 10.1017/S0266462303000345 12862195
53. National Collaborating Centre for Acute Care The management of faecal incontinence in adults: Appendices A-N London: Royal College of Surgeons of England 2006
54. Janssen-Heijnen MLG Coebergh J-WW The changing epidemiology of lung cancer in Europe Lung Cancer 2003, 41:245-258. 10.1016/ S0169-5002(03)00230-7 12928116
55. Chouaýd C Molinier L Combescure C Daures JP Housset B Vergnenegre A Economics of the clinical management of lung cancer in France: An analysis using a Markov model British Journal of Cancer 2004, 90:397-402. 10.1038/sj.bjc.6601547 14735183
56. van Iersel CA de Koning HJ Draisma G Mali WPTM Scholten ET Nackaerts K Prokop M Habbema JDF Oudkerk M van Klaveren RJ Risk-based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON) International Journal of Cancer 2006, 120:868-874. 10.1002/ijc.22134
57. Cassidy A Duffy SW Myles JP Liloglou T Field JK Lung cancer risk prediction: A tool for early detection International Journal of Cancer 2006, 120:1-6. 10.1002/ijc.22331
58. van Klaveren RJ de Koning HJ Mulshine J Hirsch FR Lung cancer screening by spiral CT: What is the optimal target population for screening trials? Lung Cancer 2002, 38:243-252. 10.1016/S0169-5002(02)00222-2 12445745
59. Pauk N Kubýk A Zatloukal P Krepela E Lung cancer in women Lung Cancer 2005, 48:1-9. 10.1016/j.lungcan.2004.10.009 15777966
60. Sculpher MJ Pang FS Manca A Drummond MF Golder S Urdahl H Davies LM Eastwood A Generalisability in economic evaluation studies in healthcare: A review and case studies Health Technology Assessment 2004, 8(49):1-192. 15544708
61. Claxton K Sculpher M Culyer A McCabe C Briggs A Akehurst R Buxton M Brazier J Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion Health Economics 2006, 15:1-4. 10.1002/hec.1081 16365910
62. Hjelmgren J Berggren F Andersson F Health economic guidelines - similarities, differences and some implications Value in Health 2001, 4:225-250. 10.1046/j.1524-4733.2001.43040.x 11705185
63. Frew E Wolstenholme JL Atkin W Whynes DK Estimating time and travel costs incurred in clinic based screening: Flexible sigmoidoscopy screening for colorectal cancer Journal of Medical Screening 1999, 6:119-123. 10572841
64. Bos JM Beutels P Annemans L Postma MJ Valuing prevention through economic evaluation: Some considerations regarding the choice of discount model for health effects with focus on infectious diseases Pharmacoeconomics 2004, 22:1171-1179. 10.2165/00019053-200422180-00002 15606224
65. Bos JM Postma MJ Annemans L Discounting health effects in pharmacoeconomic evaluations: Current controversies Pharmacoeconomics 2005, 23:639-649. 10.2165/00019053-200523070-00001 16173156
66. Gravelle H Brouwer W L N Postma M Rutten F Discounting in economic evaluations: Stepping forward towards optimal decision rules Health Economics 2007, 16:307-317. 10.1002/hec.1168 17006970
67. Schnoll RA Bradley P Miller SM Unger M Babb J Cornfeld M Psychological issues related to the use of spiral CT for lung cancer early detection Lung Cancer 2003, 39:315-325. 10.1016/S0169-5002(02)00501-9 12609570
68. Rakowski W Clark MA Ehrich B Smoking and cancer screening for women ages 42-57: Associations in the 1990-1994 National Health Interview Surveys Preventive Medicine 1999, 29:487-495. 10.1006/pmed.1999.0578 10600429
69. Carlos RC Underwood W III Fendrick AM Bernstein SJ Behavioral associations between prostate and colon cancer screening Journal of the American College of Surgeons 2005, 200:216-223. 10.1016/ j.jamcollsurg.2004.10.015 15664097
70. Silvestri G Nietert P Zoller J Carter C Bradford D Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts Thorax 2007, 62:126-130. 10.1136/thx.2005.056036 17101739
71. Hahn EJ Rayens MK Hopenhayn C Christian WJ Perceived risk and interest in screening for lung cancer among current and former smokers Research in Nursing and Health 2006, 29:359-370. 10.1002/nur.20132
72. Gray NM Sharp L Cotton SC Masson LF Little J Walker LG Avis M Philips Z Russell I Whynes D Psychological effects of a low-grade abnormal cervical smear test result: Anxiety and associated factors British Journal of Cancer 2006, 94:1253-1262. 10.1038/sj.bjc.6603086 16622462
73. Al-Shahi Salman R Whiteley WN Warlow C Screening using whole-body magnetic resonance imaging scanning: Who wants an incidentaloma? Journal of Medical Screening 2007, 14:2-4. 10.1258/096914107780154530 17362563